Home › Funds › ORBIMED ADVISORS LLC › QTTB
ORBIMED ADVISORS LLC position in QTTB
Q32 Bio Inc · Health Care
ORBIMED ADVISORS LLC reported holding 4,127,987 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$52.6M, representing 1.06% of its reported portfolio and ranking #30 among its reported holdings. ORBIMED ADVISORS LLC has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's QTTB position evolved
ORBIMED ADVISORS LLC first disclosed a stake in QTTB in Q1 2024 at 2,252,987 shares (US$38.4M). The position peaked in Q3 2024 at 2,252,987 shares, worth US$100.5M. Across 10 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 4,127,987 shares valued at US$52.6M — an increase of 1,875,000 shares quarter over quarter.. Notable position changes include a 83% increase in Q2 2026 (shares fell 35% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 2.25M | $38.39M | New |
| Q2 2024 | 2.25M | $40.44M | Hold |
| Q3 2024 | 2.25M | $100.53M | Hold |
| Q4 2024 | 2.25M | $7.75M | Hold |
| Q1 2025 | 2.25M | $3.72M | Hold |
| Q2 2025 | 2.25M | $3.36M | Hold |
| Q3 2025 | 2.25M | $4.46M | Hold |
| Q4 2025 | 2.25M | $7.48M | Hold |
| Q1 2026 | 2.25M | $14.46M | Hold |
| Q2 2026 | 4.13M | $52.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About QTTB and 13F data
QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include Boxer Capital Management, LLC (US$40.1M), Atlas Venture Life Science Advisors, LLC (US$34.6M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- Boxer Capital Management, LLC 3.15M sh · $40.12M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $34.62M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Logos Global Management LP 800.00K sh · $10.19M · Q2 2026
- Sanofi 244.08K sh · $3.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K sh · $769.02K · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held QTTB?
ORBIMED ADVISORS LLC has disclosed QTTB holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is ORBIMED ADVISORS LLC's current position in QTTB?
As of Q2 2026, ORBIMED ADVISORS LLC holds 4.13M shares of QTTB (Q32 Bio Inc), valued at $52.59M, representing 1.06% of its reported portfolio and ranking #30.
Has ORBIMED ADVISORS LLC been buying or selling QTTB?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC increased its position in QTTB. The position peaked in Q3 2024 at 2.25M shares.
Which other funds hold QTTB?
Other major institutional holders of QTTB include Boxer Capital Management, LLC, Atlas Venture Life Science Advisors, LLC, BVF INC/IL, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.